The European Medicines Agency said in a statement that it could decide within weeks whether to approve Pfizer's application for a conditional marketing authorization for the drug Paxlovid.

Join The Ecosystem

Leave a Reply

Your email address will not be published. Required fields are marked

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}